Anna Westerdahl

Anna Westerdahl is a Clinical Study Manager at Sobi - Swedish Orphan Biovitrum AB (publ) since October 2022. Prior to this, Anna held various roles in clinical operations and project management at companies such as Oncopeptides AB, TFS - Clinical Contract Research Organization, and Medivir AB. With a solid educational background in medical research and biology from institutions like Karolinska Institutet and Linköping University, Anna has accumulated extensive experience in managing and coordinating clinical trials, overseeing project delivery, and conducting monitoring activities.